Robert Hamilton Pierce - Feb 3, 2021 Form 3/A - Amendment Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Chief Scientific Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Feb 3, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
8/10/2021, 05:38 PM
Date Of Original Report
Feb 3, 2021
Next filing
Aug 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SNSE Common Stock 95.8K Feb 3, 2021 By spouse F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were omitted from the reporting person's original Form 3.
F2 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.